Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
dc.contributor.author | Escandon, Julia | |
dc.contributor.author | Peacock, Stephanie | |
dc.contributor.author | Trabolsi, Asaad | |
dc.contributor.author | Thomas, David B | |
dc.contributor.author | Layka, Ayman | |
dc.contributor.author | Lutzky, Jose | |
dc.date.accessioned | 2021-02-01T19:07:02Z | |
dc.date.available | 2021-02-01T19:07:02Z | |
dc.date.issued | 2017-12 | |
dc.date.updated | 2021-02-01T19:06:59Z | |
dc.identifier.issn | 2051-1426 | |
dc.identifier.uri | ||
dc.language | en | |
dc.publisher | BMJ | |
dc.relation.ispartof | Journal for ImmunoTherapy of Cancer | |
dc.relation.isversionof | 10.1186/s40425-016-0205-2 | |
dc.title | Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor | |
dc.type | Journal article | |
pubs.issue | 1 | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Pathology | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Clinical Science Departments | |
pubs.publication-status | Published | |
pubs.volume | 5 |
Files
Original bundle
1 - 1 of 1